I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Jack Schuler Biography and Net Worth

Major Shareholder of Soleno Therapeutics

Jack W. Schuler serves as Independent Director of the Company. since June 26, 2012. Mr. Schuler is a founding partner of Crabtree Partners, a private equity investment firm. Mr. Schuler served as a director of Ventana Medical Systems, Inc. from 1991 and as Chairman of the Board from 1995 until Ventana’s acquisition by Roche in 2008. Mr. Schuler served as a director of Stericycle, Inc. (NASDAQ: SRCL) from March 1990 to May 2018, formerly serving as Chairman of the Board. Prior to his retirement, Mr. Schuler held various executive positions at Abbott Laboratories from December 1972 through August 1989, most recently serving as President and Chief Operating Officer. He is currently a director of Quidel Corporation (NASDAQ: QDEL). Mr. Schuler holds a B.S. in Mechanical Engineering from Tufts University and an M.B.A. from Stanford University.

What is Jack W. Schuler's net worth?: The estimated net worth of Jack W. Schuler is at least $1.40 billion as of November 20th, 2024. Mr. Schuler owns 31,094,935 shares of Soleno Therapeutics stock worth more than $1,404,869,163 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Schuler may own. Learn More about Jack W. Schuler's net worth.
How do I contact Jack W. Schuler?: The corporate mailing address for Mr. Schuler and other Soleno Therapeutics executives is 203 REDWOOD SHORES PARKWAY SUITE 500, REDWOOD CITY CA, 94065. Soleno Therapeutics can also be reached via phone at (650) 213-8444 and via email at [email protected]. Learn More on Jack W. Schuler's contact information.
Has Jack W. Schuler been buying or selling shares of Soleno Therapeutics?: Jack W. Schuler has not been actively trading shares of Soleno Therapeutics in the last ninety days. Most recently, Jack W. Schuler sold 22,681 shares of the business's stock in a transaction on Friday, August 26th. The shares were sold at an average price of $2.41, for a transaction totalling $54,661.21. Following the completion of the sale, the insider now directly owns 466,666 shares of the company's stock, valued at $1,124,665.06. Learn More on Jack W. Schuler's trading history.
Who are Soleno Therapeutics' active insiders?: Soleno Therapeutics' insider roster includes Anish Bhatnagar (CEO), James Mackaness (CFO), and Jack Schuler (Major Shareholder). Learn More on Soleno Therapeutics' active insiders.
Are insiders buying or selling shares of Soleno Therapeutics?: In the last twelve months, insiders at the sold shares 20 times. They sold a total of 1,579,354 shares worth more than $75,448,230.75. The most recent insider tranaction occured on October, 1st when insider Kristen Yen sold 3,108 shares worth more than $153,628.44. Insiders at Soleno Therapeutics own 12.3% of the company. Learn More about insider trades at Soleno Therapeutics.
Information on this page was last updated on 10/1/2024.

Jack W. Schuler Insider Trading History at Soleno Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/26/2022	Sell	22,681	$2.41	$54,661.21	466,666
8/24/2022	Sell	10,888	$2.50	$27,220.00	497,741
8/22/2022	Sell	4,571	$2.68	$12,250.28	508,802
8/19/2022	Sell	7,876	$2.73	$21,501.48	513,373
8/17/2022	Sell	5,212	$2.90	$15,114.80	532,082
8/15/2022	Sell	53,333	$2.93	$156,265.69	545,012
8/12/2022	Sell	16,667	$2.65	$44,167.55	598,345
8/10/2022	Sell	8,006	$2.65	$21,215.90	617,687
8/8/2022	Sell	6,824	$2.64	$18,015.36	625,693
8/4/2022	Sell	5,103	$2.46	$12,553.38	639,213
8/2/2022	Sell	353	$2.55	$900.15	646,836
2/10/2022	Sell	800	$0.35	$280.00
5/18/2021	Sell	41,195	$1.03	$42,430.85
5/5/2021	Sell	248,115	$1.14	$282,851.10
4/30/2021	Sell	5,625	$1.25	$7,031.25
4/28/2021	Sell	80,498	$1.26	$101,427.48
4/8/2021	Sell	248,636	$1.21	$300,849.56
3/4/2021	Sell	172,717	$2.62	$452,518.54
2/25/2021	Sell	200	$2.71	$542.00
2/22/2021	Sell	700	$2.97	$2,079.00
2/18/2021	Sell	258,300	$2.95	$761,985.00
2/3/2021	Sell	14,700	$2.13	$31,311.00
1/27/2021	Sell	100	$2.05	$205.00
1/25/2021	Sell	12,818	$2.06	$26,405.08
1/21/2021	Sell	15,566	$2.10	$32,688.60
1/19/2021	Sell	29,723	$2.05	$60,932.15
1/15/2021	Sell	35,231	$2.11	$74,337.41
1/4/2021	Sell	102,000	$1.99	$202,980.00
6/26/2020	Buy	7,575,759	$1.65	$12,500,002.35
6/10/2020	Buy	339,083	$1.97	$667,993.51
5/20/2020	Buy	33,900	$1.93	$65,427.00
5/13/2020	Buy	10,572	$1.99	$21,038.28
5/9/2020	Buy	7,300	$2.00	$14,600.00
5/7/2020	Buy	200	$1.99	$398.00
5/1/2020	Buy	200	$1.96	$392.00
4/25/2020	Buy	1,200	$1.99	$2,388.00
4/22/2020	Buy	10,818	$1.99	$21,527.82
4/17/2020	Buy	20,769	$1.94	$40,291.86
4/15/2020	Buy	21,953	$1.99	$43,686.47
4/12/2020	Buy	6,000	$2.08	$12,480.00
4/8/2020	Buy	2,100	$2.03	$4,263.00
4/5/2020	Buy	47,293	$2.05	$96,950.65
4/3/2020	Buy	10,000	$2.09	$20,900.00
4/1/2020	Buy	146,230	$1.96	$286,610.80
3/29/2020	Buy	11,243	$2.09	$23,497.87
3/27/2020	Buy	100,000	$2.05	$205,000.00
3/25/2020	Buy	30,014	$2.31	$69,332.34
3/21/2020	Buy	111,407	$2.32	$258,464.24
12/21/2018	Buy	3,031,002	$1.61	$4,879,913.22

Jack W. Schuler Buying and Selling Activity at Soleno Therapeutics

Soleno Therapeutics Company Overview

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Today's Range

Now: $45.18

$44.19

$46.57

50 Day Range

MA: $52.93

$45.18

$59.18

2 Week Range

Now: $45.18

$35.70

$60.92

Volume

1,282,833 shs

Average Volume

494,505 shs

Market Capitalization

$1.95 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Jack Schuler Biography and Net Worth

What is Jack W. Schuler's net worth?

How do I contact Jack W. Schuler?

Has Jack W. Schuler been buying or selling shares of Soleno Therapeutics?

Who are Soleno Therapeutics' active insiders?

Are insiders buying or selling shares of Soleno Therapeutics?

Jack W. Schuler Insider Trading History at Soleno Therapeutics

Jack W. Schuler Buying and Selling Activity at Soleno Therapeutics

Soleno Therapeutics Company Overview

Today's Range

50 Day Range

2 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta